 Concert Pharmaceuticals, Inc. NASDAQ:CNCE Q3 2022 Earnings Conference Call November 7, 2022 8:30 AM ET Company Participants Justine Koenigsberg - Senior Vice President, Corporate Communications and Investor Relation Roger Tung - President and Chief Executive Officer Marc Becker - Chief Financial Officer James Cassella - Chief Development Officer Nancy Stuart - Chief Operating Officer Conference Call Participants Maury Raycroft - Jefferies Leszek Sulewski - Truist Sean Kim - JonesTrading Jason Butler - JMP Securities Operator Good day and thank you for standing by. And welcome to Concert Pharmaceuticals Third Quarter 2022 Investor Call. 